We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
18 own
15 watching
Current Price
$214.45
$-5.53
(-2.51%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
39,844.81M
52-Week High
285.61
52-Week Low
165.75
Average Volume
0.9M
Dividend Yield
--
P/E Ratio
62.9416
Market Capitalization39,844.81M
52-Week High285.61
52-Week Low165.75
Average Volume0.9M
Dividend Yield--
P/E Ratio62.9416
What does the Stockal+Disclaimer.pdf do?
Quintiles IMS Holdings, Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order to life science companies, and investment and financial sectors that deal with life science companies; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level to pharmaceutical sales organizations. This segment also provides OneKey, a reference database of healthcare professionals; real-world insights, and various cloud-based applications and related implementation services; and strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services. The Research & Development Solutions segment offers biopharmaceutical development services comprising project management and clinical monitoring, clinical trial support, and strategic planning and design services, as well as clinical trial, genomic, and bioanalytical laboratory services. The Integrated Engagement Services segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. Quintiles IMS Holdings, Inc. serves pharmaceutical, biotechnology, medical device, and healthcare companies. The company was formerly known as Quintiles Transnational Holdings Inc. and changed its name to Quintiles IMS Holdings, Inc. as a result of its merger with IMS Health Holdings, Inc. in October 2016. The company was founded in 1982 and is headquartered in Durham, North Carolina.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Business Wire
19days ago
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a long-term collaboration with Clalit, the largest health services organization in Israel, to launch the first Prime Site in the...
Ticker Report
1month ago
Dynamic Advisor Solutions LLC lifted its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV Get Rating) by 9.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,401 shares of the medical ...
Zolmax
1month ago
IQVIA Holdings Inc. (NYSE:IQV Get Rating) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 2,520,000 shares, a growth of 12.0% from the August 31st total of 2,250,000 shares. Approximately 1.4% of the ...
Business Wire
2 months ago
IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc. This marks the first instance of a DCT...
Ticker Report
2 months ago
Graham Capital Management L.P. raised its position in IQVIA Holdings Inc. (NYSE:IQV Get Rating) by 471.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,160 shares of the medical research company&#...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$214.45
$-5.53
(-2.51%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00